[Change in central hemodynamics in lymphoma patients]

Area of Science:

• Oncology
• Cardiology
• Pharmacology

Background:

• Lymphoma is associated with significant hemodynamic alterations.
• Polychemotherapy regimens can induce cardiotoxicity.
• Understanding these effects is crucial for patient management.

Purpose of the Study:

• To investigate hemodynamic features in lymphoma patients.
• To assess the hemodynamic impact of polychemotherapy.

Main Methods:

• Echocardiography was used to evaluate central hemodynamics.
• Study included 42 patients diagnosed with lymphoma.

Main Results:

• Lymphoma patients showed tachycardia and a trend toward left ventricular eccentric remodeling.
• These hemodynamic changes were exacerbated during polychemotherapy.
• Tumor progression markers, immune changes, and impaired hemopoiesis correlated with hemodynamic alterations.

Conclusions:

• Polychemotherapy significantly impacts hemodynamics in lymphoma patients.
• Cardioprotective strategies are essential to mitigate cardiotoxicity.
• Proactive cardiac care should be integrated into lymphoma treatment protocols.